锘� AstraZeneca's COVID jab slightly less effective vs variant found in India, CEO tells FT | Inquirer 黑料社

.simplePullQuote{--wpr-bg-80436ef2-f379-4af1-8438-cdfcc0bcd5b5: url('/single2017/images/quote-2021.png');}.simplePullQuote{--wpr-bg-72a9594a-df0f-4341-a41a-c8b3a587288e: url('/single2017/images/quote-texture.png');}.simplePullQuote{--wpr-bg-27e9d588-ca73-448f-9281-9f3a636c874d: url('/single2017/images/quote-2021.png');}.simplePullQuote{--wpr-bg-28b9a227-7043-4aed-9e25-ab6f12f28410: url('/single2017/images/quote-texture.png');}.simplePullQuote{--wpr-bg-cee1a2b0-713b-4a09-b299-4bfacbe33923: url('/single2017/images/quote-2021.png');}.simplePullQuote{--wpr-bg-83e7236d-1bf5-4beb-a9b6-2d191e586b72: url('/single2017/images/quote-texture.png');}.simplePullQuote{--wpr-bg-15530b79-ec6a-4825-b76d-06557f593571: url('/single2017/images/quote-2021.png');}.simplePullQuote{--wpr-bg-7d8f06d3-21f7-4534-bc17-9a60fe251a2b: url('/single2017/images/quote-texture.png');}.simplePullQuote{--wpr-bg-da230e98-0328-4c74-aa0c-8df2fb4db2da: url('/single2017/images/quote-2021.png');}.simplePullQuote{--wpr-bg-39bd0630-e500-4826-8a22-22ed3390d6fa: url('/single2017/images/quote-texture.png');}.simplePullQuote{--wpr-bg-bd7725d4-30ec-4d05-9a41-ebe6e4b74f12: url('/single2017/images/quote-2021.png');}.simplePullQuote{--wpr-bg-efc2c08a-b6f0-40e0-9011-6911889daf3e: url('/single2017/images/quote-texture.png');}.simplePullQuote{--wpr-bg-d9442e6e-eb82-4acb-8f24-f19b8f2b05ef: url('/single2017/images/quote-2021.png');}.simplePullQuote{--wpr-bg-90844114-60dd-41a5-8da9-327cb64f72fb: url('/single2017/images/quote-texture.png');}.sib-flag{--wpr-bg-64f2f43c-dd36-40dc-9550-5d21e12a0ed4: url('https://static.brevo.com/images/flags.png');}.simplePullQuote{--wpr-bg-ef1ce0e6-7280-41e1-8595-c97e490bb0d9: url('/wp-content/plugins/simple-pull-quote/images/quote.png');}.rll-youtube-player .play{--wpr-bg-11fefc89-55d9-4014-90ba-ff5e8a52d7dc: url('/wp-content/plugins/wp-rocket/assets/img/youtube.png');}#inq-banner-2021-FT-survey{--wpr-bg-eb4fe826-1950-4248-b285-14ab5038342c: url('https://www.inquirer.net/wp-content/uploads/2024/12/SMDC-HenrySy_980x80.gif');}#inq-banner-2021-FT-survey{--wpr-bg-488e6567-d0dd-41c8-992e-ff3c11c3599f: url('https://www.inquirer.net/wp-content/uploads/2024/12/SMDC-HenrySy_980x80.gif');}#inq-banner-2021-FT-survey{--wpr-bg-ad278c1d-8b52-41df-bfa5-19b256ea9c53: url('https://www.inquirer.net/wp-content/uploads/2024/12/SMDC-HenrySy_980x80.gif');}#inq-banner-2021-FT-survey{--wpr-bg-980ebed8-fca3-449f-8789-c1c8c817f007: url('https://www.inquirer.net/wp-content/uploads/2024/12/SMDC-HenrySy_300x75.gif');}#inq-banner-2021-FT-survey{--wpr-bg-0f827458-29b4-4ac8-99e0-f644228f4962: url('https://www.inquirer.net/wp-content/uploads/2024/12/SMDC-HenrySy_300x75.gif');}#inq-banner-2021-FT-survey{--wpr-bg-61efde70-787a-43b6-8457-332b2464224e: url('https://www.inquirer.net/wp-content/uploads/2024/12/SMDC-HenrySy_300x75.gif');}#inq-banner-2021-FT-survey{--wpr-bg-774d827f-9082-464a-b290-68bd1f9c6149: url('https://www.inquirer.net/wp-content/uploads/2024/12/SMDC-HenrySy_300x75.gif');}#inqplus-cta-wrap{--wpr-bg-3def05b8-1dab-46f4-bb3c-c6c7d5b546e8: url('/single2017/images/inqplus-sub/inqplus-cta-bg1.png');}#newsletter-cta-wrap{--wpr-bg-c7d8a6c0-ff38-430e-b221-5379b6c139df: url('/single2017/images/inqplus-sub/inqplus-cta-bg1.png');}

黑料社

FOLLOW US:

Subscribe to our daily newsletter

Your subscription could not be saved. Please try again.

Your subscription has been successful.

By providing an email address. I agree to the and acknowledge that I have read the .

AstraZeneca’s COVID jab slightly less effective vs variant found in India, CEO tells FT

Reuters / 05:28 AM May 22, 2021

AstraZeneca's COVID jab slightly less effective vs variant found in India, CEO tells FT

FILE PHOTO: The logo for AstraZeneca is seen outside its North America headquarters in Wilmington, Delaware, U.S., March 22, 2021. REUTERS/Rachel Wisniewski

AstraZeneca’s COVID-19 vaccine was only slightly less effective against the variant first found in India than the strain identified in Kent, the company’s Chief Executive Officer Pascal Soriot said in an interview with Financial Times on Friday.

He added the company is in talks with governments, including the United Kingdom, about new contracts for booster doses.

Your subscription could not be saved. Please try again.

Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the and acknowledge that I have read the .

For more news about the novel coronavirus click
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this

READ NEXT

DOH: Vaccination pace up at 108K shots daily

COVID-19 jab can win you a cow

EDITORS' PICK

Tulfo: I was an undocumented worker in US; that鈥檚 the only mistake I made

MOST READ

Tulfo: I was an undocumented worker in US; that鈥檚 the only mistake I made

LTO revokes almost聽 1,000 driver鈥檚 licenses

newsinfo

Tulfo: I was an undocumented worker in US; that鈥檚 the only mistake I made

technology

business

opinion

sports

cebudailynews

TAGS: AstraZeneca, COVID-19, efficaccy, vaccine

Your subscription could not be saved. Please try again.

Your subscription has been successful.

Disclaimer: Comments do not represent the views of 黑料社. We reserve the right to exclude comments which are inconsistent with our editorial standards. FULL DISCLAIMER

© Copyright 1997-2025 黑料社 | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies.